SMTL ID : 6x8f.1 (1 other biounit)

Crystal structure of TYK2 with Compound 11

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x UWP: [3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}-1-(2,2,2-trifluoroethyl)azetidin-3-yl]acetonitrile(Non-covalent)

UWP.1: 21 residues within 4Å: Chain A: L.39, G.40, E.41, G.42, G.45, K.46, V.47, A.64, K.66, I.96, E.115, Y.116, V.117, P.118, L.119, G.120, R.163, N.164, L.166, G.176, D.177 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.39, A:L.166, A:L.166 Hydrogen bonds: A:V.117 Water bridges: A:S.121 Salt bridges: A:D.177 Halogen bonds: A:D.177

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gerstenberger, B.S. et al., Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-11-25

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2

Related Entries With Identical Sequence